Skip to content

Autophagy Maintains Vascular Function Through a Novel Glycolysis-linked Pathway Regulating eNOS

Autophagy Maintains Vascular Function Through a Novel Glycolysis-linked Pathway Regulating eNOS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04200560
Enrollment
16
Registered
2019-12-16
Start date
2018-07-01
Completion date
2022-05-30
Last updated
2022-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Diseases

Keywords

Aging, Endothelial Cell Autophagy

Brief summary

Aging is inevitable and is the primary risk factor for developing cardiovascular disease. The molecular mechanisms that drive vascular dysfunction in the context of aging are incompletely understood. The overall hypothesis is that the age-related decline in endothelial cell (EC) autophagy leads to arterial dysfunction. This study will determine whether physiological shear-stress affects autophagosome formation and nitrous oxide (NO) generation in ECs.

Detailed description

It is hypothesized that genetic autophagy suppression prevents shear-stress induced purinergic signaling to endothelial nitrous oxide synthase (eNOS) and this pathway will be evaluated in primary arterial ECs obtained from older adult (\> 60 years) and adult (18-30 years) subjects before and following rhythmic handgrip exercise that elevates brachial artery shear-rate similarly in both groups. ECs will be used to quantify markers of EC autophagy, eNOS activation, and NO generation. The study will also determine whether exercise-training attenuates the aging-associated decline in EC autophagy, and whether intact autophagy is required for training-induced vascular improvements. To evaluate this potential, it will be determined whether one-limb rhythmic handgrip exercise training by older adult (\> 60 y) human subjects is sufficient to elevate basal and shear-induced EC autophagy initiation, eNOS activation, and NO generation vs. the contralateral sedentary limb. Results from this work have tremendous potential to reveal a new therapeutic target and approach for restoring / maintaining vascular function in the aging population.

Interventions

60 minute rhythmic handgrip exercise

OTHERChronic Exercise Training

Handgrip exercise training consisting of three 60-minute training sessions per week for eight weeks.

Sponsors

University of Utah
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Candidates must be between 18 and 90 y of age * Candidates must be free of overt disease as assessed by a) medical history; b) standard blood chemistries (chem. 7 panel), c) ECG at rest; d) limb vascular examination (ankle-brachial BP index \> 0.9); e) resting BP \< 140/90 mmHg; and f) skinfold % body fat assessment. * Subjects will have a body mass index (BMI) between 19 and 30 and have plasma glucose concentrations \< 7.0 mmol/L under fasting conditions and \< 11.1 mmol/L at 120 minutes of an oral glucose tolerance test (OGTT)

Exclusion criteria

* Candidates \<18 or \>90 y of age * Candidates demonstrating abnormal ECG, ankle-brachial BP index \<0.9, resting BP \> 140/90 * Candidates demonstrating a BMI \<19 or \> 30 * Candidates demonstrating plasma glucose concentrations \> 7.0 mmol/L under fasting conditions and \> 11.1 mmol/L at 120 minutes of an oral glucose tolerance test (OGTT) * Candidates demonstrating dyslipidemia (plasma total cholesterol \> 240 mg/dl with LDL-cholesterol \> 160 mg/dl) * Candidates reporting a history of myocardial infarction, unstable cardiac ischemia, recent cardiac catheterization, carotid artery disease, transient ischemic attack * Women taking hormone replacement therapy (HRT) currently or in the preceding year will be excluded from the proposed studies due to the direct vascular effects of HRT.

Design outcomes

Primary

MeasureTime frame
Change in biomarker p62 after chronic exercise training8 weeks
Change in biomarker beclin-1 after Rhythmic Handgrip Exercise60 min
Change in biomarker Atg3 after Rhythmic Handgrip Exercise60 min
Change in biomarker Atg5 after Rhythmic Handgrip Exercise60 min
Change in biomarker Atg7 after Rhythmic Handgrip Exercise60 min
Change in biomarker Lamp1 after chronic exercise training8 weeks
Change in biomarker Lamp2 after chronic exercise training8 weeks
Change in biomarker Lamp2 after Rhythmic Handgrip Exercise60 min
Change in biomarker p62 after Rhythmic Handgrip Exercise60 min
Change in biomarker beclin-1 after chronic exercise training8 weeks
Change in biomarker Atg3 after chronic exercise training8 weeks
Change in biomarker Atg5 after chronic exercise training8 weeks
Change in biomarker Atg7 after chronic exercise training8 weeks
Change in biomarker Lamp1 after Rhythmic Handgrip Exercise60 min

Secondary

MeasureTime frame
Change in radial arterial flow rate after Rhythmic Handgrip Exercise60 min
Change in biomarker p-eNOSS1177 after Rhythmic Handgrip Exercise60 min
Change in radial arterial diameter after chronic exercise training8 weeks
Change in radial arterial flow rate after chronic exercise training8 weeks
Change in biomarker p-eNOSS1177 after chronic exercise training8 weeks
Change in radial arterial diameter after Rhythmic Handgrip Exercise60 min

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026